Depression and anxiety rates climbed by more than 25% worldwide in 2020. Yet these numbers were already alarmingly high, with millions suffering from a range of anxiety and depressive disorders along with related struggles in addiction that often accompany these conditions. Post-traumatic Stress Disorder (PTSD) alone affects 7.7 million adults in the United States, approximately 3.5% of the population. Yet the standard of care for mental health diagnosis today is keyed to subjective questionnaires and conventional tests, which take hours to complete and depend solely on patient responses to form a diagnosis. For this and other reasons, millions of those struggling with depression, anxiety, and addiction go undiagnosed and untreated.
To help close this gap in care, Senseye is building a breakthrough diagnostic platform for mental health, starting with PTSD. Using computer vision technology, this tool allows clinicians to gather insights by tracking disruptions in the sympathetic nervous system through the eyes. CEO David Zakariaie will share his vision for the platform, which can be used remotely though widely available smartphone technology to inform a truly objective diagnosis in as little as 10 minutes.